Compare MasterCard Inc (MA) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasterCard Inc vs Oscar Health Inc — how do they compare? MasterCard Inc trades at $589.14 (market cap $503.50B), while Oscar Health Inc trades at $33.37 (market cap $10.22B). The key difference: MasterCard Inc is far larger — about 49.3× Oscar Health Inc's market cap, and MasterCard Inc pays a 0.61% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold MasterCard Inc for 134 Days and Oscar Health Inc for 15 Days on average.
| MA | OSCR | |
|---|---|---|
Market Cap | $503.50B | $10.22B |
Volume | 3,390,859 | 4,123,394 |
Sector | Financials | Health |
52-Week High | $599.86 | $33.81 |
52-Week Low | $471.55 | $10.85 |
Typical Hold Time | 134 Days | 15 Days |
Enterprise Value | $516.53B | $6.57B |
Dividend Yield | 0.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mastercard (MA) trades at $574.76, up 0.82% with strong bullish technical signals. The company demonstrates robust fundamentals with 2025 revenue of $32.79B and net income of $14.97B, maintaining exceptional profit margins above 45%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $5.04 surpassing the $4.77 estimate. Analyst consensus remains overwhelmingly positive with 80% buy ratings and a $666.67 price target.
Mastercard presents a compelling growth opportunity with expanding digital payment adoption and strong financial performance. Key risks include payment industry disruption from stablecoins and AI-driven alternatives, though the company's aggressive innovation strategy positions it well. The stock trades at premium valuations (P/E 31.6) but justifies this with consistent earnings growth and market leadership.
OSCR trades at $33.1, up 0.58% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 and Q2 2026 earnings beats, with revenue growth from $11.7B in 2025 to a projected $15.3B in 2026, turning to a net profit. Analyst consensus is a $34 price target, with 31% buy ratings. Recent news highlights market share gains and raised 2026 guidance following its Investor Day.
The outlook is positive, driven by execution in the ACA market and new growth avenues, but risks include rising medical costs threatening profitability and a high P/E ratio. The stock offers growth potential if margin expansion continues as guided.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasterCard Inc
Mastercard Incorporated provides financial transaction processing services. The Company offers payment processing services for credit and debit cards, electronic cash, automated teller machines, and travelers checks. Mastercard serves customers worldwide.
Read more on MA →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
